BeiGene
Price & Volume
Stats
See more52W Range | $196.45-$385.22 |
Market Cap | $39.1B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $4.9B |
Revenue Growth (YoY) | 41% |
Gross Profit (12 Mos) | $4.2B |
Diluted EPS | $0.53 |
News
See moreYahoo Finance • last month
Strong Momentum Lifted BeOne Medicines AG (ONC) in Q3
Yahoo Finance • 2 months ago
A Fresh Look at BeOne Medicines (ONC) Valuation as Shares Gain Momentum
Yahoo Finance • 2 months ago
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied
Yahoo Finance • 2 months ago
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
About
CEO | Mr. John V. Oyler |
Address | Aeschengraben 27, Basel, Switzerland, 4051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11,000 |
